Daily FNArena News

On the back of increased expectations for Australia’s winter crop production, stockbrokers have lifted forecasts and price targets for major beneficiary Graincorp.

Southern Cross Equities has initiated coverage on QRxPharma with a Speculative Buy rating, seeing the group’s MoxDuo drug as a potential company maker.

The technical picture for the greenback looks ominous, report chartists at Barclays. This could be the start of a rally in risk assets.

A stronger Australian dollar is causing a downturn in the Australian tourism industry, with implications for various regions and sectors of the economy, CommSec reports.

Brokers agree that Australian banks are already well positioned to comply with new international banking requirements stemming from the Basel III accord. But what happens now?

The bulls in the uranium market are already looking forward to spot prices above US$50/lb.

Stockbrokers continue to see value in Platinum Australia at current share price levels.

Market strategists at UBS and JP Morgan have made some changes as “valuation” becomes more of an issue. Analysts at RBS have discovered some good news.

A glance through the latest expert views and predictions about commodities with supportive factors identified for gold, copper and oil and an update on Brazilian iron ore output.

Brokers argue the A-REIT sector is now looking a lot more like what it used to once upon a time, before the world went crazy on debt and crashed.